Literature DB >> 15050192

Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally.

Bénédicte Mugnier, Jean Roudier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15050192     DOI： 10.1016/j.jbspin.2003.10.007

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  4 in total

1.  Protein biochip array technology to monitor rituximab in rheumatoid arthritis.

Authors:  S Fabre; C Guisset; L Tatem; N Dossat; A M Dupuy; J D Cohen; J P Cristol; J P Daures; C Jorgensen
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

2.  Protein biochip array technology for cytokine profiling predicts etanercept responsiveness in rheumatoid arthritis.

Authors:  S Fabre; A M Dupuy; N Dossat; C Guisset; J D Cohen; J P Cristol; J P Daures; C Jorgensen
Journal:  Clin Exp Immunol       Date:  2008-06-18       Impact factor: 4.330

3.  Gene profiling in white blood cells predicts infliximab responsiveness in rheumatoid arthritis.

Authors:  Thierry Lequerré; Anne-Christine Gauthier-Jauneau; Carine Bansard; Céline Derambure; Martine Hiron; Olivier Vittecoq; Maryvonne Daveau; Othmane Mejjad; Alain Daragon; François Tron; Xavier Le Loët; Jean-Philippe Salier
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

4.  Variations in the metabolome in response to disease activity of rheumatoid arthritis.

Authors:  Zuzana Tatar; Carole Migne; Melanie Petera; Philippe Gaudin; Thierry Lequerre; Hubert Marotte; Jacques Tebib; Estelle Pujos Guillot; Martin Soubrier
Journal:  BMC Musculoskelet Disord       Date:  2016-08-22       Impact factor: 2.362
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.